Life Science Tools Market - Top Companies and Manufacturers

  • Report ID: 6164
  • Published Date: Jun 12, 2024
  • Report Format: PDF, PPT

Companies Dominating the Life Science Tools Landscape

    As life science tools are always developing and advancing technologically, there is intense competition in the global market for these tools. Furthermore, the industry participants employ cooperation, amalgamation, alliance, and additional inorganic expansion tactics to provide an extensive array of inventive and appealing resolutions to their clientele.

    • Agilent Technologies, Inc.
      •  Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche AG
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc. 
    • Merck KGaA
    • QIAGEN N.V. 
    • Oxford Instruments plc
    • GE HealthCare Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Hitachi Ltd. executed a stock purchase agreement with MAX Agilent Technologies, Inc. to improve customer access to genomic tools, teamed with Biosciences, Inc. to integrate the AVITI System with Sure Select target enrichment panels.
  • QIAGEN established an exclusive strategic agreement with California-based population genomics company Helix, to enhance companion diagnostics for genetic disorders.

Author Credits:  Radhika Pawar


  • Report ID: 6164
  • Published Date: Jun 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of life science tools was over USD 161 billion.

The market size for life science tools is projected to cross USD 697 billion by the end of 2036 expanding at a CAGR of 13% during the forecast period i.e., between 2024-2036.

The major players in the market are F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Oxford Instruments plc, GE HealthCare Technologies, Inc., Becton, Dickinson and Company, Shimadzu Corporation and others.

The cell biology segment is anticipated to garner a share of 35% during 2024-2036.

The North America life science tools sector is poised to hold 38% share by the end of 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample